[DOI] [PubMed] [Google Scholar] 32.Leung PY, Miyashita K, Young M, Tsao CS
Stopping Retatrutide generally leads to weight regain, making it a long-term rather than cycled medication
Consequently, this review examines the hypothesis that semaglutide might primarily serve as a prevention-oriented neuroprotective intervention rather than a disease-modifying therapy for symptomatic Alzheimers disease
With a plan that includes strong lifestyle habits, activity, dietary changes, and medical follow-up, many people retain part of their weight loss or limit the rebound
Instead, CMS is extending the duration of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
doi:10.1210/mend.16.4.0798